Novartis Seeks Emergency Block on FDA Approval of Generic Entresto

On Friday, Novartis Pharmaceuticals urgently requested that a D.C. federal judge impose a temporary restraining order to prevent the U.S. Food and Drug Administration (FDA) from approving a generic version of Entresto, their leading heart failure medication. Novartis’s move aims to shield its market stronghold amid growing pressure from generic drug manufacturers. For more details, visit the original article on Law360.